Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Raymond James Is Souring on Carvana (CVNA) Stock

By Josh Enomoto, InvestorPlace Contributor

Raymond James issued a "sell" rating on Carvana. Here’s why betting against CVNA stock is a complicated proposition.

SMCI Stock Alert: These 2 Analysts Are Weighing In on Super Micro Computer

By Josh Enomoto, InvestorPlace Contributor

Although analysts are optimistic about Super Micro Computer, the smart money is getting nervous about SMCI stock.

3 Hidden-Gem Stocks Ready to Ride a Massive Market Wave

By Josh Enomoto, InvestorPlace Contributor

After running into some February jitters earlier this week, the market may be poised for stronger returns, which then incentivizes the narrative for hidden-gem stocks.…

Profit and Purpose: 7 Standout Stocks for the Ethical Investor

By Josh Enomoto, InvestorPlace Contributor

Can you actually make money with environmental, social and governance (ESG) plays or so-called ethical stocks? Legacy interpretations imply that ethics and profits go together…

7 Contrarian Biotech Stocks to Consider Amid Sector Weakness

By Josh Enomoto, InvestorPlace Contributor

Last October, life sciences giant Thermo Fisher Scientific (NYSE:TMO) inadvertently laid out the case for contrarian biotech stocks. According to Reuters, the company revealed that…

Load More